Table 2 Assessments in the Effects of PHysical Activity in PSychosis (EPHAPS) trial

ENROLLMENT

Eligibility screen

X

Informed consent

X

Allocation

X

INTERVENTIONS

Exercise Group (EG)

Computer Gaming Skills Group (CSG)

Sociodemographic data

X

Changes in employment status

X

X

Information on tobacco, dietary habits and current level of physical activity

X

Changes in use of tobacco, dietary habits, medication

X

X

Physical examination: height; electrocardiography (ECG); medication record

X

Weight, waist circumference, blood pressure

X

X

X

Changes in medication

X

X

Body composition assessment (bioelectrical impedance analysis/Tanita-weight)

X

X

X

Blood analyses: glucose, HbA1c, C-peptide, lipids (total cholesterol, HDL, LDL, TGA), homocystein, prolactin, T4, TSH, BDNF

X

X

X

Spirometry (pulmonary function test)

X

X

X

Maximal oxygen consumption

X

X

X

ActiGraph accelerometers (4 days)

X

X

X

Attitudes towards physical activity (PA)

X

Change in attitudes towards PA (two selected items from Attitudes towards PA)

X

X

International Physical Activity Questionnaire (IPAQ)

X

X

X

Assessment of insomnia: Insomnia Severity Index (ISI)

X

X

X

Selected parts of European Addiction Severity Index (EuropASI)

X

X

X

SCID section E

X

Alcohol and Drug Use Disorder Identification Test (AUDIT and DUDIT)

X

Alcohol and Drug Use Scale (AUS and DUS)

X

X

X

Fagerström test for Nicotine Dependence (FTND)

X

X

X

Saliva samples for assessing recent intake of tobacco, alcohol, illegal drugs and legal medication with abuse potential

X

X

X

General Ability Index (GAI, Wechsler Adult Intelligence Scale-version 4)

X

X

X

The Emotional Biological Motion Test

X

X

X

Matrics Consensus Cognitive Battery (MCCB)

X

X

X

The Structural Clinical Interview DSM-IV for axis I disorders (SCID-I)

X

The Positive and Negative Syndrome Scale (PANSS)

X

X

X

The Psychotic Symptom Rating Scale (PSYRATS)

X

X

X

The revised Beliefs About Voices Questionnaire (BAVQ)

X

Positive and Negative Affects Schedule (PANAS)

X

X

X

Depression: Calgary Depression Scale for Schizophrenia (CDSS)

X

X

X

WHO-5 Well-Being Index

X

X

X

Self-esteem (Ad Morrison)

Clinical Global Impression Scale (CGI)

X

X

X

Global Assessment of Functioning (GAFs and GAFf)

X

X

X

Quality of Life (Strauss Carpenter Level of Function (SCLOF))

X

X

X

Insight of illness: Birchwood Insight Scale; cognitive insight: Beck Cognitive Insight Scale

X

X

X

Adherence to treatment: The Believes about Medicines Questionnaire (BMQ)

X

X

X

Apathy: Apathy Evaluation Scale (AES)

X

X

X